Homepage
Medication Guide
What is Pemazyre (Pemigatinib)?
Pemazyre (pemigatinib) is a targeted therapeutic drug approved for marketing by the U.S. FDA in 2020. It belongs to the class of kinase inhibitors and is mainly used for the treatment of specific type...
502
Thursday, September 4th, 2025, 16:40
Precautions for the Administration of Alpelisib (Piqray)
Alpelisib (Piqray) is a phosphatidylinositol-3-kinase (PI3K) inhibitor administered orally, and strict adherence to dosage adjustments and adverse reaction monitoring is required.Precautions for the A...
502
Thursday, September 4th, 2025, 16:37
Indications for Cemiplimab
Cemiplimab is an immune checkpoint inhibitor primarily used for treating specific types of skin cancer. It activates the patient's own immune system to attack tumor cells by blocking the PD-1 path...
503
Thursday, September 4th, 2025, 15:07
Indications for Cemiplimab
Cemiplimab (trade name: LIBTAYO) is an innovative immunotherapeutic drug that activates the human immune system to fight tumors by targeting the PD-1 pathway.I. Indications for Cemiplimab1. Cutaneous ...
502
Thursday, September 4th, 2025, 14:58
Side Effects of Cemiplimab
As an immune checkpoint inhibitor, Cemiplimab has shown significant efficacy in the treatment of malignant tumors such as cutaneous squamous cell carcinoma. However, its use may also be accompanied by...
502
Thursday, September 4th, 2025, 14:51
How to Use Cemiplimab
Cemiplimab is an immune checkpoint inhibitor used in the treatment of specific cancers. It activates the patient's own immune system to attack tumor cells by blocking the PD-1 pathway.How to Use C...
503
Thursday, September 4th, 2025, 14:47
Dosage of cemipalimab (Cemiplimab)
Cemiplimab is an immune checkpoint inhibitor antibody targeting PD-1, used in the treatment of various advanced or metastatic tumors. Mastering the proper usage and dosage is crucial for exerting the ...
504
Thursday, September 4th, 2025, 14:40
Market Price of Genuine Ivosidenib
Ivosidenib is a therapeutic drug for acute myeloid leukemia (AML) targeting specific gene mutations, and its market price has attracted significant attention from patients and their families. So, what...
503
Wednesday, September 3rd, 2025, 16:53
Ivosidenib Package Insert
Ivosidenib is a targeted therapeutic drug for relapsed or refractory acute myeloid leukemia (AML) in patients with isocitrate dehydrogenase 1 (IDH1) mutation. This article will provide a comprehensive...
502
Wednesday, September 3rd, 2025, 16:50
Ivosidenib Price
Ivosidenib is a targeted therapeutic drug for relapsed or refractory acute myeloid leukemia (AML) in patients with IDH1 mutations. This article will explore three aspects—price, side effects, and miti...
501
Wednesday, September 3rd, 2025, 16:48
107 / 186
1852 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved